Name | Bromo-PEG2-azide |
Synonyms | Br-PEG2-N3 N3-PEG2-Br Azido-PEG2-Br Bromo-PEG2-azide N3-PEG2-CH2CH2Br Azido-PEG3-bromide Bromo-PEG2-C2-azide 1-(2-Azidoethoxy)-2-(2-bromoethoxy)ethane |
CAS | 530151-56-5 |
Molecular Formula | C6H12BrN3O2 |
Molar Mass | 238.08238 |
Storage Condition | -20°C |
In vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 4.2 ml | 21.001 ml | 42.002 ml |
5 mM | 0.84 ml | 4.2 ml | 8.4 ml |
10 mM | 0.42 ml | 2.1 ml | 4.2 ml |
5 mM | 0.084 ml | 0.42 ml | 0.84 ml |
biological activity | Bromo-PEG2-C2-azide is a non-degradable ADC linker for the synthesis of antibody-conjugated drugs (ADCS). Bromo-PEG2-C2-azide is also a PEG-based PROTAC linker and can be used in the synthesis of PROTAC. |